In Other Journals

Med J Aust 2005; 182 (5): . || doi: 10.5694/j.1326-5377.2005.tb06663.x
Published online: 7 March 2005

US investigators have suggested that lowering serum C-reactive protein (CRP) levels (with statins or other anti-inflammatory agents) could reduce vascular risk in patients with acute coronary syndromes. The PROVE IT-TIMI 22 Investigators studied serum CRP and LDL cholesterol levels in 3745 patients receiving statin therapy (80 mg atorvastatin or 40 mg pravastatin, daily) after an acute myocardial infarction or for unstable angina. Irrespective of the serum LDL cholesterol level achieved, patients with low (< 2mg/L) serum CRP levels after statin therapy had better clinical outcomes than those with higher levels.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.